Vincent P. Sandanayaka,Sharon Shechter,Sharon Shacham,Dilara McCauley,Erkan Baloglu
申请号：
US15413889
公开号：
US20170319551A1
申请日:
2017.01.24
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to compounds of formula I:and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
